Stock & Company Details
Context Therapeutics Inc $CNTX
Price:
N/A
N/A
92M
$15M
52 Week High:
N/A
10 Day Average Volume:
N/A
-0.35
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Services
CNTX technical indicators
Latest Context Therapeutics Inc (CNTX) indicator readings as of 2026-11-19.
CNTX's 14-day RSI is 31.8, in neutral territory. ADX reads 44.6, indicating a trending market. MACD (12, 26, 9) is -0.03, below the zero line.
Overview
Context Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to improving the lives of women living with cancer. The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer.
Finance Bot
Ask your questions
Start by typing a question below.